A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(Formerly HF 2252.)
Impact
The implementation of HF2456 is expected to dramatically improve the experience of accessing healthcare information for individuals with disabilities. The bill sets forth obligations for pharmacy service providers to deliver accessible materials in a timely manner comparable to those provided to non-disabled individuals. The inclusion of input from the affected community during the rule-making process aims to ensure that the measures adopted genuinely reflect the needs and preferences of the users, fostering inclusivity within healthcare services.
Summary
House File 2456 is legislated to enhance accessibility for individuals who are blind, visually impaired, or have print disabilities. The bill mandates the state's pharmacy board to develop rules ensuring that these individuals can access prescription drug labels, bag tags, and medical guides without incurring any additional costs. A critical deadline established by the bill requires these accessibility measures to be implemented by October 31, 2024. This legislation signifies a move towards making healthcare information more equitable for all residents, particularly those with disabilities.
Contention
While the bill has gained support for its noble goal of promoting accessibility, potential points of contention include the burden of compliance on pharmacies, particularly smaller independent pharmacies that may face operational challenges in meeting the legislative requirements. Additionally, there may be debates concerning the adequacy of the timeline given for rollout and whether the board of pharmacy can effectively enforce compliance among all pharmaceutical providers, thereby ensuring that the provisions of the law translate into practical improvements for those who need them.
Similar To
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
Similar To
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(See HF 2456.)
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.(See HF 2456.)
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
A bill for an act relating to ensuring the provision of accessible prescription-related measures for persons who are blind, have a visual impairment, or otherwise have print disabilities.
State Board of Pharmacy - Accessible Prescription Labels, Bag Tags, and Medical Guides for Blind, Visually Impaired, and Print Disabled Individuals - Regulations
State Board of Pharmacy - Accessible Prescription Labels, Bag Tags, and Medical Guides for Blind, Visually Impaired, and Print Disabled Individuals - Regulations
A bill for an act relating to Medicaid-related programs and services including the work without worry program for employed individuals with disabilities and complex rehabilitation technology.(Formerly HF 403, HSB 198.)
Pharmacist dispensing of prescriptions using an audible container or braille container label for patients who are visually impaired or blind requirement
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.